AH
Asad Haider Goldman Sachs Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
15
Avg Return
Past Year
Past Year
12%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
40%
Neutral
53.3%
Negative
6.7%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Upgraded
| $142 |
68%
upside
| 2 | -21% |
0
%
| 16 Jan ‘26 1 month ago |
|
|
|
Buy
Maintained
| $240 |
2%
downside
| 3 | +18% |
0
%
| 19 Dec ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $37 |
19%
upside
| 2 | – |
–
| 2 Dec ‘25 3 months ago |
|
|
|
Neutral
Maintained
| $57 |
6%
downside
| 2 | – |
–
| 2 Dec ‘25 3 months ago |
|
|
|
Sell
Initiated
| $17 |
25%
downside
| 1 | -18% |
0
%
| 30 Sep ‘25 5 months ago |
|
|
|
Buy
Initiated
| $42 |
9%
downside
| 1 | +31% |
0
%
| 30 Sep ‘25 5 months ago |
|
|
|
Neutral
Initiated
| $38 |
35%
downside
| 1 | – |
–
| 12 Sep ‘25 5 months ago |
|
|
|
Buy
Upgraded
| $888 |
11%
downside
| 1 | +38% |
0
%
| 8 Apr ‘25 11 months ago |
|
|
|
Neutral
Assumed
| $194 |
15%
downside
| 1 | – |
–
| 8 Apr ‘25 11 months ago |
|
|
|
Neutral
Downgraded
| $25 |
8%
downside
| 1 | – |
–
| 8 Apr ‘25 11 months ago |
|